This Guidewire Software Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Guidewire Software, Inc.
Kestra Medical Technologies Ltd.
Csquare, Inc.
Standard Nuclear, Inc. Class A

Guidewire Software, Inc.

GWRE

0.00

Kestra Medical Technologies Ltd.

KMTS

0.00

Csquare, Inc.

CSQR

0.00

Standard Nuclear, Inc. Class A

STDN

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst Billy Fitzsimmons initiated coverage on Guidewire Software Inc (NYSE:GWRE) with an Overweight rating and announced a price target of $210. Guidewire closed at $170.53 on Friday. See how other analysts view this stock.
  • JP Morgan analyst Robbie Marcus initiated coverage on Kestra Medical Technologies Ltd (NASDAQ:KMTS) with an Overweight rating and announced a price target of $30. Kestra Medical shares closed at $26.40 on Friday. See how other analysts view this stock.
  • Morgan Stanley analyst Cameron McVeigh initiates coverage on Csquare Inc (NYSE:CSQR) with an Overweight rating and announced a price target of $26. Csquare closed at $21.52 on Friday. See how other analysts view this stock.
  • Stifel analyst Stephen Gengaro initiated coverage on Standard Nuclear Inc (NYSE:STDN) with a Buy rating and announced a price target of $16. Standard Nuclear shares closed at $8.44 on Friday. See how other analysts view this stock.
  • B of A Securities analyst Michael Funk initiated coverage on Csquare Inc (NYSE:CSQR) with a Buy rating and announced a price target of $46. Csquare closed at $21.52 on Friday. See how other analysts view this stock.

Considering buying GWRE stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.